about
Genetic variants at the IFNL3 locus and their association with hepatitis C virus infections reveal novel insights into host-virus interactionsNew virologic tools for management of chronic hepatitis B and CMicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation.IL28B polymorphisms and clinical implications for hepatitis C virus infection in UzbekistanOnce-daily simeprevir (TMC435) with pegylated interferon and ribavirin in treatment-naïve genotype 1 hepatitis C: the randomized PILLAR study.The association of toll-like receptor 4 polymorphism with hepatitis C virus infection in Saudi Arabian patients.A single nucleotide polymorphism associated with hepatitis C virus infections located in the distal region of the IL28B promoter influences NF-κB-mediated gene transcriptionFavourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.PharmGKB summary: peginterferon-α pathway.The genetic theory of infectious diseases: a brief history and selected illustrations.Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.Interleukin-28B rs12979860 C/T Polymorphism and Acute Cellular Rejection after Liver TransplantationIntroduction to the genetics and biology of interleukin-28B.The role of pharmacogenetics in the treatment of chronic hepatitis C infection.Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study.Protease inhibitor therapy post-liver transplantation in the treatment of hepatitis C virus infection.Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients.
P2860
Q27014831-3B28463B-63CF-42D7-91DA-2010FFB0D941Q27026914-87124183-7DBB-4DFA-8A66-CC018156FA24Q30456389-919B6EDB-E6BF-47EE-A43C-A400628240B1Q31154491-2D26C5B5-D142-424B-9D57-1D02EFB0A2E0Q33956796-B10439B6-D76D-4653-80F1-166F2FAA8F3AQ34081261-F71CCADE-F7C1-44DF-ABA9-3CAB10564BF4Q35014462-7412D3C0-56E5-4933-BC5C-8115388D3438Q35381792-8EAFE851-6B53-4318-A8C4-9892DBFFC217Q36590755-64DB276F-1010-4A6E-8A6B-ADDE498F7DE8Q37166962-A0517D9B-D940-4B86-A1A6-C8F6995935E1Q37385600-77951414-8778-40D1-9A3A-72D89EF1C012Q37695717-92076FBF-1008-471E-B729-D541A67ED0A3Q38003354-2B45175A-E496-4342-B14A-945D66240E1BQ38151586-ADB0D4BF-D1BA-4F3E-8446-263001AA1DC4Q40873893-A96930BE-65C6-48F9-AFA3-EB807C295E7BQ42089879-01F111C7-6EE0-411B-8CEE-46FE7C5B24D3Q42263068-7298DAC1-B2A8-4E49-8E2E-A55949C918B9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Host genomics and HCV treatment response.
@en
Host genomics and HCV treatment response.
@nl
type
label
Host genomics and HCV treatment response.
@en
Host genomics and HCV treatment response.
@nl
prefLabel
Host genomics and HCV treatment response.
@en
Host genomics and HCV treatment response.
@nl
P2860
P1476
Host genomics and HCV treatment response
@en
P2093
Alexander J Thompson
P2860
P304
P356
10.1111/J.1440-1746.2011.06918.X
P50
P577
2012-02-01T00:00:00Z